Skip to main content
OpenTrials

Clinical trial condition

Moderate to Severe Palmoplantar Psoriasis

Explore clinical trials studying Moderate to Severe Palmoplantar Psoriasis. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Moderate to Severe Palmoplantar Psoriasis trial results

Completed

Study of Safety, Tolerability, and Efficacy of Secukinumab in Subjects With Moderate to Severe Palmoplantar Psoriasis

NCT01806597

Conditions
Moderate to Severe Palmoplantar Psoriasis, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, +6 more
Locations
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Novartis Investigative Site Phoenix, Arizona, United States
  • Novartis Investigative Site Indianapolis, Indiana, United States
  • Novartis Investigative Site Louisville, Kentucky, United States
View all 54 locations
View Trial Details

Related conditions